The technology can provide assistance to pharmaceutical and nutraceutical companies to remotely monitor production machine settings, performance parameters, machine downtimes, and alarms in real time over the Smart Connected dashboard. The machine performance will be studied by experts who can then guide customers on how to better maintain and operate the machines.
Speaking on how the smart connect product can improve efficiency, Marcus Michel, CEO, ACG Engineering said, “We are excited to unveil the Smart Connected Product as part of our Smart Connected campaign. This initiative demonstrates ACG’s commitment to provide data-centric, end to end solutions under the principle of predictive maintenance. Our overall aim is to reduce costs as well as lower any safety, health, environment and quality risks – all to ensure superior manufacturing performance. Detailed insights and information from our experts will help provide guidance to our customers on how to make machines run more efficiently and prevent unplanned downtime. Amid the evolving healthcare landscape, the Smart Connected product is a step forward to ensure an undisrupted supply chain.”
ACG has also launched a “Smart Connected” campaign to raise awareness on how pharma manufacturers can collaborate with ACG to remotely monitor their ACG equipment, improve their efficiencies and reduce unplanned downtimes. The messaging of the campaign will focus on how IIoT-based solutions can help pharmaceutical manufacturers use valuable data to analyze machine performance and improve Overall Equipment Effectiveness.